SCHEMBL1306843

SCHEMBL1306843

CC(CCCC=C(COc1cccc2ccccc12)C(=O)NC1CCN(C2CC2)CC1)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ P2RX3 P56373 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CASP3 P42574 3/20 0.36
▸ CASP1 P29466 2/20 0.36
▸ CASP7 P55210 2/20 0.36
▸ CASP8 Q14790 2/20 0.36
▸ PREP P48147 2/20 0.36
▸ CASP6 P55212 1/20 0.35
▸ OGG1 O15527 1/20 0.35
▸ MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1308082 0.97 KMT2A (0.40) KMT2AMEN1P2RX3ALDH1A1KDM4E
SCHEMBL1306858 0.91 ALDH1A1 (0.39) KMT2AMEN1P2RX3ALDH1A1KDM4E
SCHEMBL1307235 0.90 P2RX3 (0.40) KMT2AMEN1P2RX3ALDH1A1KDM4E
SCHEMBL1308301 0.89 KMT2A (0.48) KMT2AMEN1P2RX3ALDH1A1KDM4E
SCHEMBL1306121 0.89 KMT2A (0.37) KMT2AMEN1P2RX3ALDH1A1KDM4E
SCHEMBL1307084 0.88 P2RX3 (0.41) KMT2AMEN1P2RX3ALDH1A1KDM4E
SCHEMBL1306209 0.87 ALDH1A1 (0.44) KMT2AMEN1P2RX3ALDH1A1KDM4E
SCHEMBL1306207 0.87 ALDH1A1 (0.44) KMT2AMEN1P2RX3ALDH1A1KDM4E
SCHEMBL1307949 0.87 P2RX3 (0.50) P2RX3
SCHEMBL1306839 0.85 CNR2 (0.40) P2RX3ALDH1A1KDM4EHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8053435-B2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-11-08 — — US disclosed
Send feedback